Alteco Medical has signed a distributor agreement with ACT Medical Ltd in Israel and Palestine.
Through the agreement, ACT Medical is entitled to exclusive rights to market and sell Alteco LPS Adsorber on the local market.
The first step is to register the product with the relevant authorities – and this process will be handled with urgency, considering the ongoing pandemic. Meanwhile, Alteco will provide product training and ACT will promote the product and its concept to key customers in the region.
Alteco Medical CEO Fredrik Jonsson says:
–It’s great to have a partner in Israel, where the Alteco LPS Adsorber has potential within sepsis and heart surgery. Israel is an important market for us, given that a lot of documentation, publications etcetera meet high international standards.
